Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thats great news
Painkillers in Military-From USA Today article on 3/17/10
Abuse of pain pills by troops concerns Pentagon
Updated 3/17/2010 12:15 PM | Comments 142 | Recommend 12 E-mail | Save | Print | Reprints & Permissions |
Enlarge By Maya Alleruzzo, AP
U.S. soldiers board a Blackhawk helicopter after searching an island on the Tigris river in Mosul, Iraq.
PAINKILLER USE RISING
Number of prescriptions that military doctors wrote for painkillers
Source: Defense Department
By Gregg Zoroya, USA TODAY
WASHINGTON — The military is trying to curb the volume of narcotics given to troops as the number of prescriptions for painkillers and instances of drug abuse continue to soar, according to Pentagon data and recent congressional testimony.
Military doctors wrote almost 3.8 million prescriptions for pain relief for servicemembers last year — more than four times the 866,773 doses handed out in 2001, according to data from the Pentagon health office.
VIDEO: Caregiving strains families of injured vets
INTERACTIVE: A look at U.S. lives lost in Iraq, Afghanistan
"These are stunning statistics," says Sen. Jim Webb, D-Va., who intends to look into the issue next week during a Senate subcommittee hearing that he will chair. Surgeons general of the Army, Navy and Air Force will testify. "I would really like to dig down in the data here and get their thoughts about what is driving this."
Military officials and analysts say the increase in the use of narcotic pain medication reflects the continuing toll on ground troops fighting in Iraq and Afghanistan, often through more than one combat deployment. In addition to those who are wounded, larger numbers of soldiers and Marines develop aches and strains carrying heavy packs, body armor and weapons over rugged and mountainous terrain.
"Clearly the stress on the force, because of these continuous deployments, is a component (in the increasing of prescriptions)," says Webb, a member of the Senate Armed Services Committee and decorated Marine veteran of Vietnam.
The Army, which has done most of the fighting in Iraq and Afghanistan, is examining how it gives pain relief pills to its soldiers, says Assistant Army Secretary Thomas Lamont. A multiservice task force will outline how to limit prescription medication use and ensure that Army hospitals all use the same procedure for dispending medicine, he said.
"Our soldiers are coming back (from combat) wounded, sore, injured, in need of rehab," Lamont told a Senate subcommittee last week.
"We found every Army medical center was dealing with pain in altogether different ways, all individual ... but not an Army-wide program at all," Lamont says. "There was no consistency."
One in four soldiers admitted abusing prescribed drugs, mostly pain relievers, in the 12 months prior to a Pentagon survey in 2008, according to the results released this year. Fifteen percent said they had abused drugs in the 30 days before the survey.
"I think what we don't understand ... is what the motivation is," says Jack Smith, head of the clinical and program policy for the Pentagon's Health Affairs office.
More study is needed to understand why and how troops are abusing prescription medications, he says.
Pentagon records show the abuse of prescription drugs is higher in the military than among civilians. Five percent of civilians reported abusing prescription drugs in a 30-day period in 2007, compared to 11% of military personnel surveyed in 2008.
"The No. 1 thing we have to be focusing on here is the long-term well-being of the (troops)," Webb says. "They have no options in terms of deciding when, and how long, and how repeatedly they're deployed. And so it's up to the top (military) leadership and us over here (in Congress) to make sure we're taking care of their well-being."
http://www.usatoday.com/news/military/2010-03-16-military-drugs_N.htm
but you also have to remember that nutrapharma has nyloxin outside the USA and nutrapharma has the drug pipeline.
we all know what happened after the first shows earlier in the year. The stock had a nice pop.
I agree with you. Always seems like the MM's take it down a little when an important event is coming then it rockets north. The 10k is due by the end of the month. Maybe thats what is happening here.
I'm a subscriber to that theory.
Does anyone know if the government signs contracts at this upcoming battlefield summit? Could get interesting at the end of the month if NutraPharma is able to secure a military contract.
sounds like they got the gel first and the spray will be coming soon. makes sense huh.
I believe they are patenting the delivery system and or the process for cobroxin.
Where to buy it should confirm it. www.shophsg.com
Look at the print ads that xenacare did. it says to buy it at www.cobroxin.com which is their site. Why would xenacare make an ad and then tell people to buy it somewhere else. I also beleive the national tv ad will tell people to go to the retail pharmacy outlets as well as your supermarkets. I think xenacare is waiting to put the national ad out until the product is in the major pharmacy's first. It doesnt do xenacare any good to tell people to go to these pharmacy's when its not on all the shelves yet. I think when we here that cvs and walgreens have it on the shelves, we will then see national commercials.
The commercial wasnt done by Xenacare or Nutrapharma. The commercial was done by HSG. Thats why is tells people to go to their website. A national TV Ad will tell everyont to go to a retail store. I think its a great sign that HSG took it upon themselves and see the value in cobroxin to make the commercial. That should tell everyone something!
But Nutrapharma doesnt have the marketting expenses and Nutrapharma has the pipeline of other drugs in developement.
Nutra gave isserman some warrents for compensation. That's all. Nothing unusual about it.
International sales would be nyloxin and the pr specifically said cobroxin
I believe nutra did that because of the investor conferences that rik is at now. Makes sense to me. Rik is probably going to give sales info to these investors and knows he has to release a pr to everyone first. My best guess.
My guess is based on info from the web conferences. You are using sales numbers as if they sold it to a retail customer from a store. You can't do that. Everyne knows that.
They can't sell it because xcho is the only seller in the USA according to the licensing agreement
fLyers fan there is a mistake in your numbers. Nutra isn't a retailer of the finished product so you can't us $19. My guess is the price they wholesale to xcho might be $4-5 a unit. Now divide that by sales numbers nutra posted. Good try though.
65 different investors who know what their buying and its not for a measily few cents. They know the big potential that is about to pass once commercials and real sales numbers hit later in the year.
oh yes and dont forget 2012 flaflyerfan. Better get out by then right flaflyerfan. lol what a joke.
Then you have to add in south America, Europe, and canadian sales into the mix for nutrapharma sales as well. Im sure nutrapharma is also going into asia and people here have also mentioned the military as another source of sales.
To think they will all sell is more than naive since the stock hasnt taken off yet. If you believe this is the top then please sell what you have now if you have any to sell. When sales start getting announced you will understand where nutrapharma is going.
The people that obviously bought in privately believe in the company. To sell before the take off in stock price would be stupid. Thats common sense. I would believe that these investors wouldnt sell until at leat the first qtr of 2010 sales are released. Those sales would show 1 and a half to 2 months worth of TV ads. Maybe some selling then but dont be naive to think that all would sell. These people believe in what they invested in.
Well we know that commercials for cobroxin should start this month. then this will get interesting.
dont forget about the Stop and Shop chain of more than 375 stores throughout New England, New York and New Jersey.
I beleive it was paul reid who used to do research for the militay.
I believe that its only stupid if you feel the stock will go lower at that time. I feel nutra will be well up in value then. Its naive to think everyone will sell at the same time too.
I would think the people who bought those shares know what they have and would hold for qtrly results showing sales.
Theres an overstock.com banner on ihub for cobroxin too. its on rotation up top.
Those shares are restricted. So they are definately not being sold at the moment.
ALCOHOL: It has been reported that Cobroxin can lessen the overt intoxicating effects of alcohol. As the impact of this observation is not fully understood, it is recommended that you do not drink alcoholic beverages while using Cobroxin.
Does this mean i have to drink more to get a buzz???
I would also bet china and india will be future prs based on population.
they are in north america silly.
more sweet news
from yahoo board this morning. Nice info
"Some additional info from XenaCare:
To address you question about advertising....we have been on the cover of Drug Store News including an unsolicited article about Corboxin. Since we have just launched this product, we could not have advertised anywhere until product was available. We have advertised in Prevention, Star, Woman's World, Self, Soap Opera Digest, Health and Drug Store News. We also have banneer ads on multiple networks and by Jan, on WebMD. We will also have Arthritis Today.
Going forward, we will also be doing TV spots etc..."
meaning people cant borrow shares to short. only way to short now is naked.
nphc and xcho are now both of the shortable stock list ftom interactivebrokers.com nice
do you remember from the cohen research report that shows nutra as a short term price projection of 1.78. Those numbers were based on the pessimistic sales of cobroxin from page 3 under valuations below. Well nutra shipping more than a million units already blows the most optimistic numbers from the cohen report.
We project revenues of approximately $0.6 million in 2009 and $179.2 million in 2018. These projections
are based on funding requirements of approximately $3.0 million between 2009 and 2010.
We expect Cobroxin to penetrate the $8.0 billion OTC pain market translating into initial sales of $0.5
million in Q4 2009. Operating margins are expected to improve from -29% in 2010 to 44% by 2013.
We have valued the stock using Discounted Cash flow (DCF) method to arrive at our long term price
target of $3.15, reflecting forward P/S multiples of 357.8 and 160.0x our estimated 2010 and 2011
Sales, respectively. Our short-term price target of $1.78 and intermediate term price target of $2.46 is
based on Price/Capital employed ratio. We believe our valuation is conservative.
Degreed on tylenol. You mean this company came out with a pill to make minor pains go away, thats hogwash. show me a study. no wait studies can be manipulated. lets see what people have to say taking it. but i wont believe testimonials, these people can be lying. now that i think about it, nothing anyone says can make me believe it works. lololol
you guys are really ruining degreeds day by always proving him wrong.